Download FREE Report Sample
Download Free sampleLeuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.
Leuprolide Market contains market size and forecasts of Leuprolide in Global, including the following market information:
Global Leuprolide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Leuprolide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Subcutaneous Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Leuprolide include TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, AbbVie, Bayer, Takeda and Beijing Boente Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Leuprolide companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leuprolide Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Leuprolide Market Segment Percentages, by Type, 2021 (%)
Subcutaneous
Topical
Global Leuprolide Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Leuprolide Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Endometriosis
Precocious Puberty
Prostate Cancer
Uterine Fibrosis
Other
Global Leuprolide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Leuprolide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leuprolide revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Leuprolide revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
TOLMAR PHARMACEUTICALS
Sanofi
Teva
Sandoz (Novartis)
Sun Pharmaceutical
AbbVie
Bayer
Takeda
Beijing Boente Pharmaceutical
Livzon Pharmaceutical
Selleck
Hangzhou Peptide Biochemical
Chengdu Shenguo Biological Pharmaceutical
SciAnda Pharma
Daewoong
GP Pharm
Enteris BioPharma
Chong Kun Dang
Leadiant Biosciences
Hikma Pharmaceuticals
Lee Pharma
Hanall
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
